Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nakamura H, Sawamura D, Goto M, et al. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta. Int J Mol Med, 2006,18(2):333–337
Has C, Spartà G, Kiritsi D, et al. Integrin a3 mutations with kidney, lung, and skin disease. N Engl J Med, 2012,366(16):1508–1514
Ashton GH, Sorelli P, Mellerio JE, et al. Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol, 2001,144(2):408–414
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 2009,25(14):1754–1760
Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics, 2009,25(16):2078–2079
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 2010,38(16):e164
Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res, 2003,31(13):3812–3814
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods, 2010,7(4):248–249
Schwarz JM, Rodelsperger C, Schuelke M, et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods, 2010,7(8):575–576
Chun S, Fay JC. Identification of deleterious muta-tions within three human genomes. Genome Res, 2009,19(9):1553–1561
Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res, 2011,39(17):e118
Yang H, Robinson PN, Wang K. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat Methods, 2015,12(9):841–843
Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet, 2017,100(2):267–280
Vaisanen L, Has C, Franzke C, et al. Molecular mechanisms of junctional epidermolysis bullosa: Col 15 domain mutations decrease the thermal stability of collagen XVII. J Invest Dermatol, 2005,125(6):1112–1118
Gelse K, Poschl E, Aigner T. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev, 2003,55(12):1531–1546
Xiao J, Cheng H, Silva T, et al. Osteogenesis imperfecta missense mutations in collagen: structural consequences of a glycine to alanine replacement at a highly charged site. Biochemistry, 2011,50(50):10 771–10 780
Floeth M, Fiedorowicz J, Schacke H, et al. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa. J Invest Dermatol, 1998,111(3):528–533
Shinkuma S. Dystrophic epidermolysis bullosa: a review. Clin Cosmet Investig Dermatol, 2015,8:275–284
McGrath JA, Gatalica B, Christiano AM, et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet, 1995,11(1):83–86
Pasmooij AM, Pas HH, Jansen GH, et al. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands. Br J Dermatol, 2007,156(5):861–870
Bauer JW, Lanschuetzer C. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy. Clin Exp Dermatol, 2003,28(1):53–60
Bruckner-Tuderman L, Has C. Molecular Heterogeneity of Blistering Disorders: The Paradigm of Epidermolysis Bullosa. J Invest Dermatol, 2012,132(Suppl 3):E2–5
Lucky AW, Dagaonkar N, Lammers K, et al. A comprehensive next-generation sequencing assay for the diagnosis of epidermolysis bullosa. Pediatr Dermatol, 2018,35(2):188–197
Takeichi T, Liu L, Fong K, et al. Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory. Br J Dermatol, 2015,172(1):94–100